TY - JOUR AU - Giantonio, B. J. AU - Catalano, P. J. AU - Meropol, N. J. AU - O’Dwyer, P. J. AU - Mitchell, E. P. AU - Alberts, S. R. PY - 2007 DA - 2007// TI - Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200 JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2006.09.6305 DO - 10.1200/JCO.2006.09.6305 ID - Giantonio2007 ER - TY - JOUR AU - Sandler, A. AU - Gray, R. AU - Perry, M. C. AU - Brahmer, J. AU - Schiller, J. H. AU - Dowlati, A. PY - 2006 DA - 2006// TI - Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer JO - N Engl J Med VL - 355 UR - https://doi.org/10.1056/NEJMoa061884 DO - 10.1056/NEJMoa061884 ID - Sandler2006 ER - TY - JOUR AU - Vredenburgh, J. J. AU - Desjardins, A. AU - Herndon, J. E. AU - Marcello, J. AU - Reardon, D. A. AU - Quinn, J. A. PY - 2007 DA - 2007// TI - Bevacizumab plus irinotecan in recurrent glioblastoma multiforme JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.12.2440 DO - 10.1200/JCO.2007.12.2440 ID - Vredenburgh2007 ER - TY - JOUR AU - Escudier, B. AU - Pluzanska, A. AU - Koralewski, P. AU - Ravaud, A. AU - Bracarda, S. AU - Szczylik, C. PY - 2007 DA - 2007// TI - Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial JO - Lancet VL - 370 UR - https://doi.org/10.1016/S0140-6736(07)61904-7 DO - 10.1016/S0140-6736(07)61904-7 ID - Escudier2007 ER - TY - JOUR AU - Cutsem, E. AU - Tabernero, J. AU - Lakomy, R. AU - Prenen, H. AU - Prausova, J. AU - Macarulla, T. PY - 2012 DA - 2012// TI - Addition of aflibercept to fluorouracil, leucovorin, and irinotecan improves survival in a phase III randomized trial in patients with metastatic colorectal cancer previously treated with an oxaliplatin-based regimen JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2012.42.8201 DO - 10.1200/JCO.2012.42.8201 ID - Cutsem2012 ER - TY - JOUR AU - Mucci, L. A. AU - Powolny, A. AU - Giovannucci, E. AU - Liao, Z. AU - Kenfield, S. A. AU - Shen, R. PY - 2009 DA - 2009// TI - Prospective study of prostate tumor angiogenesis and cancer-specific mortality in the health professionals follow-up study JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.8876 DO - 10.1200/JCO.2008.20.8876 ID - Mucci2009 ER - TY - JOUR AU - Kelly, W. K. AU - Halabi, S. AU - Carducci, M. AU - George, D. AU - Mahoney, J. F. AU - Stadler, W. M. PY - 2012 DA - 2012// TI - Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401 JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.39.4767 DO - 10.1200/JCO.2011.39.4767 ID - Kelly2012 ER - TY - JOUR AU - Tannock, I. F. AU - Fizazi, K. AU - Ivanov, S. AU - Karlsson, C. T. AU - Flechon, A. AU - Skoneczna, I. PY - 2013 DA - 2013// TI - Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70184-0 DO - 10.1016/S1470-2045(13)70184-0 ID - Tannock2013 ER - TY - JOUR AU - Brufsky, A. M. AU - Hurvitz, S. AU - Perez, E. AU - Swamy, R. AU - Valero, V. AU - O’Neill, V. PY - 2011 DA - 2011// TI - RIBBON-2: a randomized, double-blind, placebo-controlled, phase III trial evaluating the efficacy and safety of bevacizumab in combination with chemotherapy for second-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.34.1255 DO - 10.1200/JCO.2010.34.1255 ID - Brufsky2011 ER - TY - JOUR AU - Perren, T. J. AU - Swart, A. M. AU - Pfisterer, J. AU - Ledermann, J. A. AU - Pujade-Lauraine, E. AU - Kristensen, G. PY - 2011 DA - 2011// TI - A phase 3 trial of bevacizumab in ovarian cancer JO - N Engl J Med VL - 365 UR - https://doi.org/10.1056/NEJMoa1103799 DO - 10.1056/NEJMoa1103799 ID - Perren2011 ER - TY - JOUR AU - Koch, S. AU - Claesson-Welsh, L. PY - 2012 DA - 2012// TI - Signal transduction by vascular endothelial growth factor receptors JO - Cold Spring Harb Perspect Med VL - 2 UR - https://doi.org/10.1101/cshperspect.a006502 DO - 10.1101/cshperspect.a006502 ID - Koch2012 ER - TY - JOUR AU - Neufeld, G. AU - Sabag, A. D. AU - Rabinovicz, N. AU - Kessler, O. PY - 2012 DA - 2012// TI - Semaphorins in angiogenesis and tumor progression JO - Cold Spring Harb Perspect Med VL - 2 UR - https://doi.org/10.1101/cshperspect.a006718 DO - 10.1101/cshperspect.a006718 ID - Neufeld2012 ER - TY - JOUR AU - Bender, R. J. AU - Mac Gabhann, F. PY - 2013 DA - 2013// TI - Expression of VEGF and semaphorin genes define subgroups of triple negative breast cancer JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0061788 DO - 10.1371/journal.pone.0061788 ID - Bender2013 ER - TY - JOUR AU - Lehmann, B. D. AU - Bauer, J. A. AU - Chen, X. AU - Sanders, M. E. AU - Chakravarthy, A. B. AU - Shyr, Y. PY - 2011 DA - 2011// TI - Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies JO - J Clin Invest VL - 121 UR - https://doi.org/10.1172/JCI45014 DO - 10.1172/JCI45014 ID - Lehmann2011 ER - TY - JOUR AU - Knezevic, D. AU - Goddard, A. D. AU - Natraj, N. AU - Cherbavaz, D. B. AU - Clark-Langone, K. M. AU - Snable, J. PY - 2013 DA - 2013// TI - Analytical validation of the Oncotype DX prostate cancer assay -- a clinical RT-PCR assay optimized for prostate needle biopsies JO - BMC Genomics VL - 14 UR - https://doi.org/10.1186/1471-2164-14-690 DO - 10.1186/1471-2164-14-690 ID - Knezevic2013 ER - TY - JOUR AU - Erho, N. AU - Crisan, A. AU - Vergara, I. A. AU - Mitra, A. P. AU - Ghadessi, M. AU - Buerki, C. PY - 2013 DA - 2013// TI - Discovery and validation of a prostate cancer genomic classifier that predicts early metastasis following radical prostatectomy JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0066855 DO - 10.1371/journal.pone.0066855 ID - Erho2013 ER - TY - JOUR AU - Cooperberg, M. R. AU - Simko, J. P. AU - Cowan, J. E. AU - Reid, J. E. AU - Djalilvand, A. AU - Bhatnagar, S. PY - 2013 DA - 2013// TI - Validation of a cell-cycle progression gene panel to improve risk stratification in a contemporary prostatectomy cohort JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.46.4396 DO - 10.1200/JCO.2012.46.4396 ID - Cooperberg2013 ER - TY - JOUR AU - Bismar, T. A. AU - Demichelis, F. AU - Riva, A. AU - Kim, R. AU - Varambally, S. AU - He, L. PY - 2006 DA - 2006// TI - Defining aggressive prostate cancer using a 12-gene model JO - Neoplasia VL - 8 UR - https://doi.org/10.1593/neo.05664 DO - 10.1593/neo.05664 ID - Bismar2006 ER - TY - JOUR AU - Irshad, S. AU - Bansal, M. AU - Castillo-Martin, M. AU - Zheng, T. AU - Aytes, A. AU - Wenske, S. PY - 2013 DA - 2013// TI - A molecular signature predictive of indolent prostate cancer JO - Sci Transl Med VL - 5 ID - Irshad2013 ER - TY - JOUR AU - Wu, C. L. AU - Schroeder, B. E. AU - Ma, X. J. AU - Cutie, C. J. AU - Wu, S. AU - Salunga, R. PY - 2013 DA - 2013// TI - Development and validation of a 32-gene prognostic index for prostate cancer progression JO - Proc Natl Acad Sci U S A VL - 110 UR - https://doi.org/10.1073/pnas.1215870110 DO - 10.1073/pnas.1215870110 ID - Wu2013 ER - TY - JOUR AU - Yu, Y. P. AU - Landsittel, D. AU - Jing, L. AU - Nelson, J. AU - Ren, B. AU - Liu, L. PY - 2004 DA - 2004// TI - Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy JO - J Clin Oncol VL - 22 UR - https://doi.org/10.1200/JCO.2004.05.158 DO - 10.1200/JCO.2004.05.158 ID - Yu2004 ER - TY - JOUR AU - Grasso, C. S. AU - Wu, Y. M. AU - Robinson, D. R. AU - Cao, X. AU - Dhanasekaran, S. M. AU - Khan, A. P. PY - 2012 DA - 2012// TI - The mutational landscape of lethal castration-resistant prostate cancer JO - Nature VL - 487 UR - https://doi.org/10.1038/nature11125 DO - 10.1038/nature11125 ID - Grasso2012 ER - TY - JOUR AU - Liu, W. AU - Laitinen, S. AU - Khan, S. AU - Vihinen, M. AU - Kowalski, J. AU - Yu, G. PY - 2009 DA - 2009// TI - Copy number analysis indicates monoclonal origin of lethal metastatic prostate cancer JO - Nat Med VL - 15 UR - https://doi.org/10.1038/nm.1944 DO - 10.1038/nm.1944 ID - Liu2009 ER - TY - JOUR AU - Mac Gabhann, F. AU - Popel, A. S. PY - 2006 DA - 2006// TI - Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches JO - PLoS Comput Biol VL - 2 UR - https://doi.org/10.1371/journal.pcbi.0020180 DO - 10.1371/journal.pcbi.0020180 ID - Mac Gabhann2006 ER - TY - JOUR AU - Reuter, C. W. AU - Morgan, M. A. AU - Grunwald, V. AU - Herrmann, T. R. AU - Burchardt, M. AU - Ganser, A. PY - 2007 DA - 2007// TI - Targeting vascular endothelial growth factor (VEGF)-receptor-signaling in renal cell carcinoma JO - World J Urol VL - 25 UR - https://doi.org/10.1007/s00345-007-0152-0 DO - 10.1007/s00345-007-0152-0 ID - Reuter2007 ER - TY - JOUR AU - Chu, L. H. AU - Rivera, C. G. AU - Popel, A. S. AU - Bader, J. S. PY - 2012 DA - 2012// TI - Constructing the angiome: a global angiogenesis protein interaction network JO - Physiol Genomics VL - 44 UR - https://doi.org/10.1152/physiolgenomics.00181.2011 DO - 10.1152/physiolgenomics.00181.2011 ID - Chu2012 ER - TY - JOUR AU - Lee, E. AU - Pandey, N. B. AU - Popel, A. S. PY - 2013 DA - 2013// TI - Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model JO - Clin Exp Metastasis VL - 31 UR - https://doi.org/10.1007/s10585-013-9610-9 DO - 10.1007/s10585-013-9610-9 ID - Lee2013 ER - TY - JOUR AU - Tretiakova, M. AU - Antic, T. AU - Binder, D. AU - Kocherginsky, M. AU - Liao, C. AU - Taxy, J. B. PY - 2013 DA - 2013// TI - Microvessel density is not increased in prostate cancer: digital imaging of routine sections and tissue microarrays JO - Hum Pathol VL - 44 UR - https://doi.org/10.1016/j.humpath.2012.06.009 DO - 10.1016/j.humpath.2012.06.009 ID - Tretiakova2013 ER - TY - JOUR AU - Bono, A. V. AU - Celato, N. AU - Cova, V. AU - Salvadore, M. AU - Chinetti, S. AU - Novario, R. PY - 2002 DA - 2002// TI - Microvessel density in prostate carcinoma JO - Prostate Cancer Prostatic Dis VL - 5 UR - https://doi.org/10.1038/sj.pcan.4500572 DO - 10.1038/sj.pcan.4500572 ID - Bono2002 ER - TY - JOUR AU - Erbersdobler, A. AU - Isbarn, H. AU - Dix, K. AU - Steiner, I. AU - Schlomm, T. AU - Mirlacher, M. PY - 2010 DA - 2010// TI - Prognostic value of microvessel density in prostate cancer: a tissue microarray study JO - World J Urol VL - 28 UR - https://doi.org/10.1007/s00345-009-0471-4 DO - 10.1007/s00345-009-0471-4 ID - Erbersdobler2010 ER - TY - JOUR AU - Schoenborn, J. R. AU - Nelson, P. AU - Fang, M. PY - 2013 DA - 2013// TI - Genomic profiling defines subtypes of prostate cancer with the potential for therapeutic stratification JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-3606 DO - 10.1158/1078-0432.CCR-12-3606 ID - Schoenborn2013 ER - TY - JOUR AU - Aryee, M. J. AU - Liu, W. AU - Engelmann, J. C. AU - Nuhn, P. AU - Gurel, M. AU - Haffner, M. C. PY - 2013 DA - 2013// TI - DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases JO - Sci Transl Med VL - 5 ID - Aryee2013 ER - TY - JOUR AU - Duque, J. L. AU - Loughlin, K. R. AU - Adam, R. M. AU - Kantoff, P. W. AU - Zurakowski, D. AU - Freeman, M. R. PY - 1999 DA - 1999// TI - Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer JO - Urology VL - 54 UR - https://doi.org/10.1016/S0090-4295(99)00167-3 DO - 10.1016/S0090-4295(99)00167-3 ID - Duque1999 ER - TY - JOUR AU - Caine, G. J. AU - Blann, A. D. AU - Stonelake, P. S. AU - Ryan, P. AU - Lip, G. Y. PY - 2003 DA - 2003// TI - Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1 JO - Eur J Clin Invest VL - 33 UR - https://doi.org/10.1046/j.1365-2362.2003.01243.x DO - 10.1046/j.1365-2362.2003.01243.x ID - Caine2003 ER - TY - JOUR AU - Singh, A. AU - Gautam, K. A. AU - Dalela, D. AU - Sankhwar, S. AU - Natu, S. AU - Sankhwar, P. PY - 2013 DA - 2013// TI - Plasma vascular endothelial growth factors A and C in patients undergoing prostatic biopsy and TURP for suspected prostatic neoplasia JO - Asian Pac J Cancer Prev VL - 14 UR - https://doi.org/10.7314/APJCP.2013.14.3.2053 DO - 10.7314/APJCP.2013.14.3.2053 ID - Singh2013 ER - TY - JOUR AU - Saylor, P. J. AU - Kozak, K. R. AU - Smith, M. R. AU - Ancukiewicz, M. A. AU - Efstathiou, J. A. AU - Zietman, A. L. PY - 2012 DA - 2012// TI - Changes in biomarkers of inflammation and angiogenesis during androgen deprivation therapy for prostate cancer JO - Oncologist VL - 17 UR - https://doi.org/10.1634/theoncologist.2011-0321 DO - 10.1634/theoncologist.2011-0321 ID - Saylor2012 ER - TY - JOUR AU - Fontana, A. AU - Galli, L. AU - Fioravanti, A. AU - Orlandi, P. AU - Galli, C. AU - Landi, L. PY - 2009 DA - 2009// TI - Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer JO - Clin Cancer Res VL - 15 UR - https://doi.org/10.1158/1078-0432.CCR-08-3317 DO - 10.1158/1078-0432.CCR-08-3317 ID - Fontana2009 ER - TY - JOUR AU - Tomic, T. T. AU - Gustavsson, H. AU - Wang, W. AU - Jennbacken, K. AU - Welen, K. AU - Damber, J. E. PY - 2012 DA - 2012// TI - Castration resistant prostate cancer is associated with increased blood vessel stabilization and elevated levels of VEGF and Ang-2 JO - Prostate VL - 72 UR - https://doi.org/10.1002/pros.21472 DO - 10.1002/pros.21472 ID - Tomic2012 ER - TY - JOUR AU - Beardsley, E. K. AU - Hotte, S. J. AU - North, S. AU - Ellard, S. L. AU - Winquist, E. AU - Kollmannsberger, C. PY - 2012 DA - 2012// TI - A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer JO - Invest New Drugs VL - 30 UR - https://doi.org/10.1007/s10637-011-9722-5 DO - 10.1007/s10637-011-9722-5 ID - Beardsley2012 ER - TY - JOUR AU - Michaelson, M. D. AU - Oudard, S. AU - Ou, Y. C. AU - Sengelov, L. AU - Saad, F. AU - Houede, N. PY - 2014 DA - 2014// TI - Randomized, Placebo-Controlled, Phase III Trial of Sunitinib Plus Prednisone Versus Prednisone Alone in Progressive, Metastatic, Castration-Resistant Prostate Cancer JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2012.48.5268 DO - 10.1200/JCO.2012.48.5268 ID - Michaelson2014 ER - TY - JOUR AU - Smith, D. C. AU - Smith, M. R. AU - Sweeney, C. AU - Elfiky, A. A. AU - Logothetis, C. AU - Corn, P. G. PY - 2013 DA - 2013// TI - Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial JO - J Clin Oncol VL - 31 UR - https://doi.org/10.1200/JCO.2012.45.0494 DO - 10.1200/JCO.2012.45.0494 ID - Smith2013 ER - TY - JOUR AU - Burton, J. B. AU - Priceman, S. J. AU - Sung, J. L. AU - Brakenhielm, E. AU - An, D. S. AU - Pytowski, B. PY - 2008 DA - 2008// TI - Suppression of prostate cancer nodal and systemic metastasis by blockade of the lymphangiogenic axis JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-08-1488 DO - 10.1158/0008-5472.CAN-08-1488 ID - Burton2008 ER - TY - JOUR AU - Jennbacken, K. AU - Vallbo, C. AU - Wang, W. AU - Damber, J. E. PY - 2005 DA - 2005// TI - Expression of vascular endothelial growth factor C (VEGF-C) and VEGF receptor-3 in human prostate cancer is associated with regional lymph node metastasis JO - Prostate VL - 65 UR - https://doi.org/10.1002/pros.20276 DO - 10.1002/pros.20276 ID - Jennbacken2005 ER - TY - JOUR AU - Segarra, M. AU - Ohnuki, H. AU - Maric, D. AU - Salvucci, O. AU - Hou, X. AU - Kumar, A. PY - 2012 DA - 2012// TI - Semaphorin 6A regulates angiogenesis by modulating VEGF signaling JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-02-410076 DO - 10.1182/blood-2012-02-410076 ID - Segarra2012 ER - TY - JOUR AU - Aihara, M. AU - Wheeler, T. M. AU - Ohori, M. AU - Scardino, P. T. PY - 1994 DA - 1994// TI - Heterogeneity of prostate cancer in radical prostatectomy specimens JO - Urology VL - 43 UR - https://doi.org/10.1016/S0090-4295(94)80264-5 DO - 10.1016/S0090-4295(94)80264-5 ID - Aihara1994 ER -